fluorouracil has been researched along with Escherichia coli Infections in 7 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Subsequent dosing with 5-FU induced lethal septicaemia caused by the inoculated strains in most of these mice, whereas CY did not regularly induce septicaemia." | 1.29 | Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice. ( Furuya, N; Hirakata, Y; Matsumoto, T; Tateda, K; Yamaguchi, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirakata, Y | 1 |
| Furuya, N | 1 |
| Matsumoto, T | 1 |
| Tateda, K | 1 |
| Yamaguchi, K | 1 |
| Murosaki, S | 1 |
| Muroyama, K | 1 |
| Yamamoto, Y | 1 |
| Kusaka, H | 1 |
| Liu, T | 1 |
| Yoshikai, Y | 4 |
| Nyhlén, A | 1 |
| Ljungberg, B | 1 |
| Nilsson-Ehle, I | 1 |
| Odenholt, I | 1 |
| Nomoto, K | 8 |
| Matsuoka, Y | 1 |
| Hayakawa, K | 1 |
| Ohwaki, M | 1 |
| Kan, T | 1 |
| Yokokura, T | 3 |
| Mitsuyama, M | 2 |
7 other studies available for fluorouracil and Escherichia coli Infections
| Article | Year |
|---|---|
Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice.
Topics: Ampicillin; Animals; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Disease Models, Anim | 1996 |
Immunopotentiating activity of nigerooligosaccharides for the T helper 1-like immune response in mice.
Topics: Animals; Antibodies, Monoclonal; Cells, Cultured; Concanavalin A; Diet; Disaccharides; Enzyme-Linked | 1999 |
Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ceftazidime; Cephalosporins; Doxorubicin; Drug Interac | 2002 |
Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model.
Topics: Animals; Antibodies, Bacterial; Cattle; Cecum; Disease Models, Animal; Escherichia coli; Escherichia | 1992 |
Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation.
Topics: Animals; Bacterial Vaccines; Escherichia coli Infections; Fibrosarcoma; Fluorouracil; Lacticaseibaci | 1992 |
Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation.
Topics: Adjuvants, Immunologic; Animals; Biological Factors; Escherichia coli Infections; Fluorouracil; Hema | 1992 |
Induction of lethal infection with indigenous Escherichia coli in mice by fluorouracil.
Topics: Administration, Oral; Animals; Cephalothin; Escherichia coli; Escherichia coli Infections; Fluoroura | 1991 |